|
|
(27 intermediate revisions by 2 users not shown) |
Line 1: |
Line 1: |
| {{Tongji_China/Head_N_Prefix}} | | {{Tongji_China/Head_N_Prefix}} |
− | <html>
| + | {{Tongji_China/userDefault}} |
− | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/Template:Tongji_China/userDefault?action=raw&ctype=text/css">
| + | |
− | </html>
| + | |
| {{Tongji_China/Head_N_Suffix}} | | {{Tongji_China/Head_N_Suffix}} |
| {{Tongji_China/Header_N}} | | {{Tongji_China/Header_N}} |
| <html> | | <html> |
− |
| |
| <head> | | <head> |
− | <meta charset="UTF-8">
| + | <meta charset="UTF-8"> |
− | <title>Programme</title>
| + | <title>Dry Lab</title> |
| </head> | | </head> |
− |
| |
| <body> | | <body> |
− | <div class="background"> | + | <div class = "background"> |
| + | <div class="content"> |
| <div class="title"> | | <div class="title"> |
| Dry Lab | | Dry Lab |
| + | </div> |
| + | <div class="title_2"> |
| + | Overview |
| </div> | | </div> |
− | <div class="logoPicture">
| + | With information of colorectal cancer mutations from the TCGA database, we use “mutated” CDSs centered by the mutation sites and use an 8~14aa long slide window to cut the amino acid sequences around each mutated site. Then we put these amino sequences into NetMHC and predict their immunogenicity. We choose strong biding peptides for later use. <br><br> |
− | <img src="https://static.igem.org/mediawiki/2018/c/c1/T--Tongji_China--picture-drylab-model-0.png" width="15%" height="25%"> | + | |
| </div> | | </div> |
− | <div class="title_2"> | + | <div class="linkOfPicture" style="text-align:center"> |
− | Model
| + | <a href="/Team:Tongji_China/Programme" class="test_a"><img src="https://static.igem.org/mediawiki/2018/f/fb/T--Tongji_China--picture-Dry_Lab-Overview-1_Programming.png" class="linkpicture2" \></a> |
− | </div>
| + | |
− | <div class="content">
| + | |
− | <p><I>Acknowledge:CPU China. This part is made by Team CPU China and thanks for their collaboration!</I></p>
| + | |
− | We use Bayesian statistics to predict which type of mutation is most likely to product MHC strong binding peptides with the sum of affinity of each mutation site and each allele type.<br>
| + | |
− | Bayesian statistics is a theory in the field of statistics based on the Bayesian interpretation of probability where probability expresses a degree of belief in an event. The degree of belief may be based on prior knowledge about the event, such as the results of previous experiments, or on personal beliefs about the event. This differs from a number of other interpretations of probability, such as the frequentist interpretation that views probability as the limit of the relative frequency of an event after a large number of trials.<br>Bayes' theorem is a fundamental theorem in Bayesian statistics, as it is used by Bayesian methods to update probabilities, which are degrees of belief, after obtaining new data. Given two events A and B, the conditional probability of A given that B is true is expressed as follows:<br>
| + | |
− | <p style="text-align:center"><img src="https://static.igem.org/mediawiki/2018/8/82/T--Tongji_China--picture-drylab-model-1.png" width="25%" height="25%"></p>
| + | |
− | Although Bayes' theorem is a fundamental result of probability theory, it has a specific interpretation in Bayesian statistics. In the above equation, <I>A</I> usually represents a proposition (such as the statement that a coin lands on heads fifty percent of the time) and <I>B</I> represents the evidence, or new data that is to be considered (such as the result of a series of coin flips). <I>P(A)</I> is the prior probability of <I>A</I> which expresses one's beliefs about <I>A</I> before evidence is considered. The prior probability may also quantify prior knowledge or information about <I>A</I>. <I>P(B|A)</I> is the likelihood function, which can be interpreted as the probability of the evidence <I>B</I> given that <I>A</I> is true. The likelihood quantifies the extent to which the evidence <I>B</I> supports the proposition <I>A</I>. <I>P(A|B)</I> is the posterior probability, the probability of the proposition B into account. Essentially, Bayes' theorem updates one's prior beliefs <I>P(A)</I> after considering the new evidence <I>B</I>.<br>
| + | |
− | The probability of the evidence <I>P(B)</I> can be calculated using the law of total probability. If <I>{A1, A2, …, An}</I> is a partition of the sample space, which is the set of all outcomes of an experiment, then,<br>
| + | |
− | <p style="text-align:center"><img src="https://static.igem.org/mediawiki/2018/b/b8/T--Tongji_China--picture-drylab-model-2.png" width="90%" height="90%"></p>
| + | |
− | The formulation of statistical models using Bayesian statistics has the identifying feature of requiring the specification of prior distributions for any unknown parameters. Indeed, parameters of prior distributions may themselves have prior distributions, leading to Bayesian hierarchical modeling, or may be interrelated, leading to Bayesian networks.<br><br>
| + | |
− | We use Bayesian statistics to predict which type of mutation is most likely to product MHC strong binding peptides with the sum of affinity of each mutation site and each allele type. Bayesian statistics is a theory in the field of statistics based on the Bayesian interpretation of probability where probability expresses a degree of belief in an event. If a colorectal cancer patient is detected to have immune response to our medicine, we can predict which mutation is playing the strongest role in the cancer using this model. If a patient's mutation sites are already known, this model can also help predict which site can be the best one for peptide making for this certain patient which contributes to the individualized therapy. <br>The heatmap below shows the sum of affinity of each allele type and each mutation.<br>
| + | |
− | <p style="text-align:center"><img src="https://static.igem.org/mediawiki/2018/e/e4/T--Tongji_China--picture-drylab-model-3.png" width="75%" height="75%"></p>
| + | |
− | <div class="instructionOfPicture">
| + | |
− | Figure.Model.1 Heatmap of the affinity of each allele type and each mutation.
| + | |
| | | |
− | </div> | + | <a href="/Team:Tongji_China/Modeling" class="test_a"><img src="https://static.igem.org/mediawiki/2018/1/1b/T--Tongji_China--picture-Dry_Lab-Overview-2_Modeling.png" class="linkpicture2" \></a> |
− | <br><br> | + | |
| + | </div><br><br> |
| </div> | | </div> |
| + | </body> |
| + | </html> |
| + | {{Tongji_China/Footer_N}} |